Science
Tongkat Ali and Drug Interactions: What Is Actually Known?
A cautious evidence review of Tongkat Ali and medicines: what short human extract studies can show, what remains unknown for interactions, and why dried root tea needs separate caution.
Does Tongkat Ali interact with medicines? Reliable interaction data for brewed Tongkat Ali root tea are not established. Short studies of selected extracts do not prove compatibility with prescription medicines, so people taking medicines should ask a pharmacist or prescriber before use.
What is known
The available human literature is not a reliable interaction map for Tongkat Ali products. It is limited, short-term, and centered on particular supplements rather than dried root tea.
One small double-blind crossover study enrolled 13 male recreational athletes who received a defined Physta® standardized water extract (400 mg daily) or placebo for six weeks per regimen. The paper reported no significant change in its liver or renal laboratory measures over that period. It did not establish safety with prescription medicines, identify clinically meaningful drug interactions, or test dried root tea.
What is not established
For our dried root slices, we do not have published evidence showing that they are compatible with:
- anticoagulant or antiplatelet medicines;
- blood-pressure or heart medicines;
- diabetes medicines;
- psychiatric medicines, stimulants, or sedatives;
- hormone therapies or fertility treatments;
- immune-modifying medicines;
- medicines with a narrow therapeutic range; or
- medicines whose dose depends on laboratory monitoring.
This is an evidence gap, not proof that an interaction occurs with each category. It is also not proof that no interaction occurs.
Human, animal, laboratory, and theoretical evidence are different
| Evidence level | What it can answer | What it cannot establish |
|---|---|---|
| Human interaction study | Whether a stated preparation changed a stated medicine outcome in the people studied | Safety with every medicine, every dose, or another product |
| Short human extract safety study | Selected short-term outcomes for that extract | A drug-interaction profile or root-tea compatibility |
| Animal or laboratory finding | A possible mechanism worth studying | A confirmed interaction in people |
| Theoretical concern | A reason to ask a qualified professional | That an interaction is established |
Do not treat laboratory metabolism findings, a database warning, or a shared side effect as proof of a clinical interaction unless the source documents the actual medicine, preparation, population, and outcome.
Why product form matters
Standardized extract study ≠ dried root tea ≠ this product batch.
An interaction question depends on exposure. Brewing can vary with root material, slice mass, water volume, heat, time, and repeat brewing. We do not publish the batch composition, eurycomanone concentration, contaminant panel, or pharmacokinetic data for our root slices. Those gaps prevent a confident conversion from an extract study to this tea.
When to seek professional advice
Ask the clinician or pharmacist managing your medicine before using Tongkat Ali if you:
- take any prescription medicine or more than one regular medicine;
- have liver, kidney, cardiovascular, endocrine, psychiatric, or hormone-sensitive conditions;
- are pregnant, breastfeeding, trying to conceive, or preparing for surgery; or
- use a medicine that requires dose adjustment or laboratory monitoring.
Bring the exact package details or product webpage. “Tongkat Ali” alone may not identify the preparation, other ingredients, or relevant uncertainty.
Practical safety boundaries
Do not stop, start, or adjust a prescribed medicine because of an herbal-product claim. Do not use a lack of immediate symptoms as proof of compatibility. Stop the tea and seek professional advice if a concerning new symptom appears.
For broader safety considerations, see Red Tongkat Ali Safety. For our current documentation limits, see Product Testing Status.
Sources and related reading
- Science Hub — parent research cluster
- PubMed 25013692 — short Physta® extract crossover study; not an interaction trial
- Evidence Index — source-quality and product-boundary policy
- Tongkat Ali Dosage: What Human Studies Actually Used — study-material and dose limits
- Root Slices vs Extract — why formats are not interchangeable
Frequently Asked Questions
Scientific research and product-specific testing answer different questions. See Product Batch Testing.